NeoGenomics, Inc.
NEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $198 | $187 | $242 | $417 |
| - Cash | $164 | $155 | $346 | $367 |
| + Debt | $410 | $412 | $605 | $605 |
| Enterprise Value | $444 | $444 | $500 | $656 |
| Revenue | $188 | $181 | $168 | $172 |
| % Growth | 3.6% | 7.9% | -2.3% | – |
| Gross Profit | $80 | $77 | $73 | $77 |
| % Margin | 42.8% | 42.6% | 43.6% | 44.9% |
| EBITDA | -$10 | -$28 | -$6 | $4 |
| % Margin | -5.3% | -15.2% | -3.8% | 2.1% |
| Net Income | -$27 | -$45 | -$26 | -$15 |
| % Margin | -14.4% | -24.9% | -15.4% | -8.9% |
| EPS Diluted | -1.05 | -1.75 | -1 | -0.6 |
| % Growth | 40% | -75% | -66.7% | – |
| Operating Cash Flow | $9 | $20 | -$25 | $10 |
| Capital Expenditures | -$8 | -$6 | -$5 | -$12 |
| Free Cash Flow | $1 | $14 | -$30 | -$2 |